ILoF - Personalized Medicine

ILoF - Personalized Medicine Digital health company pioneering a AI-platform enabling the future of personalized medicine

🚀 Last month, iLoF was honoured to present at the prestigious  Technology Association’s CEO Summit, one of the most excl...
22/07/2025

🚀 Last month, iLoF was honoured to present at the prestigious Technology Association’s CEO Summit, one of the most exclusive and influential gatherings of the year!

🚀This invitation-only event brought together global innovation leaders and top-tier investors, offering us the unique opportunity to engage with Fortune 500 CEOs, technological thought leaders, and industry experts., sharing how iLoF is reshaping the future of personalised medicine through our AI-powered platform.

A heartfelt thank you to - who besides being behind Las Vegas, one of the most powerful tech events in the world, is also responsible for putting together such a great platform to share and celebrate meaningful innovation. More than just an event, it was a chance to connect, learn, and be part of something bigger, and we’re proud to be involved.

Here’s to the future of tech, health, and everything in between! 🙌

Earlier this year, we had the pleasure of joining a delegation of leading european healthtech businesses, on a mission t...
12/06/2025

Earlier this year, we had the pleasure of joining a delegation of leading european healthtech businesses, on a mission to explore key opportunities in South Korea!
By meting with the most innovative players in biotech and healthcare, we were deeply impressed by the dynamism of the Korean market — a world-leading ecosystem supported by strong R&D investment, a forward-looking regulatory environment, and a collaborative spirit.
Through various connections with previous and new ecosystem partners and friends, we also had the opportunity to join the Healthcare & Medical Korea Fair in Seoul, attending 2025 and engaging in expert-led discussions that further broadened our understanding of the region’s unique strengths 🚀
The insights gained and the connections made during this mission have brought us significantly closer to that objective.
A special thanks to the Business Hub team for the impeccable organization and for facilitating such high-value exchanges.

We’re proud to have been featured in a case study by European Investment Fund (EIF), highlighting how we’re helping adva...
17/04/2025

We’re proud to have been featured in a case study by European Investment Fund (EIF), highlighting how we’re helping advance the future of personalised medicine!

In the article, we dive into how we’re using our AI-powered digital platform to reshape clinical trials, including on Alzheimer’s disease—one of the most challenging and costly areas in healthcare. By non-invasive, accurate triage, trials can benefit from reduced patient dropout, improved trial accuracy, making drug discovery faster, cheaper, and more precise.

👉 Check out the full case study here: https://www.eif.org/what_we_do/equity/Case_studies/ilof-portugal.htm

Thanks to our incredible team, partners, and backers who are helping us move healthcare towards a more personalised and data-driven future!

Last Friday, we had the privilege of taking part in the Innovation in Healthcare: Drug Discovery & Clinical Trials UK 🇬🇧...
03/04/2025

Last Friday, we had the privilege of taking part in the Innovation in Healthcare: Drug Discovery & Clinical Trials UK 🇬🇧 - Portugal 🇵🇹 panel, organised by the Department of Business and Trade and hosted at the NOVA National School of Public Health. Representing iLoF, Sara Rocha attended the event engaging with brilliant minds passionate about transforming the future of healthcare.

This initiative was also made possible with the support of AICIB - Agência de Investigação Clínica e Inovação Biomédica. We were honored to share the stage with key figures, including the Vice-President of AICIB Paula Macedo and a Board Member of AICIB Anabela Isidro, who brought invaluable insights to the discussion.

A huge thank you to the UK British Embassy Lisbon for fostering such an insightful discussion, as well as to all the outstanding speakers and participants who contributed to this enriching dialogue:
Dace Dimza-Jones | Paresh Malhotra (NIHR - National Institute for Health and Care Research) | Rosário Trindade | António Parada | Guilherme Monteiro Ferreira | Pedro Silva | Luis Costa | Tomislav Karoli |Ingrid Gouveia | Joel Passarinho | Sónia Dias (NOVA Medical School - Faculdade de Ciências Médicas).

Engaging with so many passionate professionals and exchanging ideas on the future of healthcare innovation was truly inspiring. The positive feedback we received about our participation made this experience even more rewarding! 🚀

Are you ready to take your PhD beyond academia and apply your expertise in an impactful, fast moving environment? We’re ...
27/03/2025

Are you ready to take your PhD beyond academia and apply your expertise in an impactful, fast moving environment? We’re welcoming applications for PhD scholarships 🚀

This is your chance to work on cutting-edge research with practical applications, collaborate with industry leaders, and be part of an innovative ecosystem that transforms knowledge into action.
Join a vibrant, forward-thinking environment where you can shape industries, solve real-world challenges, and drive innovation. We are inviting scholarship proposals within the areas of photonics, AI applied to healthcare, and biomedical engineering.

📩 If you're passionate about bringing research into the real world, do let us know more about you: https://forms.gle/fMue6kXUTWgR9CFW8

Honored to have been featured in the most recent article of the European Patent Office, highlighting how our cutting-edg...
20/03/2025

Honored to have been featured in the most recent article of the European Patent Office, highlighting how our cutting-edge technology is helping to reduce the cost and time of clinical trials. We’re excited to be recognized for our work in revolutionizing personalized medicine through AI and photonics.

At iLoF, we’re building a digital library of disease biomarkers to accelerate drug discovery and development, with a strong focus on cancer and Alzheimer’s disease. This recognition is a testament to the dedication of our incredible team, partners, and supporters who share our vision of transforming healthcare.

A huge thank you to the European Patent Office for this feature and to everyone who has supported us on this journey. Together, we’re pushing the boundaries of innovation to create a healthier future for all.

👉 Read the full article here:https://link.epo.org/web/publications/studies/en-epo-study-new-frontiers-in-oncology.pdf

It was a pleasure to have joined the Cruzamento Podcast, with André Correia and Daniel Guedelha, discussing the future o...
27/02/2025

It was a pleasure to have joined the Cruzamento Podcast, with André Correia and Daniel Guedelha, discussing the future of personalised medicine! 🧪

In this episode, our CEO Luís Valente shared insights on how iLoF is revolutionising personalized medicine with Optomics, a groundbreaking combination of optical data and AI. He discussed how this innovation is overcoming challenges in clinical trials, such as invasive procedures and recruitment inefficiencies.

We also took the opportunity to highlight our impactful Alzheimer’s trial partnership, sharing reflections on the challenges of being a startup and offering valuable advice for those transitioning from corporate roles to startups. The key message: success lies in hiring passionate people, fostering a sense of purpose, and prioritizing high-performing teams 🚀

A huge thanks to for this opportunity to share our mission and vision at the intersection of technology, health, and sustainability.

🎧 Listen to the full episode here: https://buff.ly/4ic4Fdy

We’re honored to share that iLoF has been named one of the winners of the prestigious Founders Games 2025, whose finale ...
20/02/2025

We’re honored to share that iLoF has been named one of the winners of the prestigious Founders Games 2025, whose finale was held in Davos, Switzerland, during the World Economic Forum! 🌟

This recognition comes after a rigorous technical, market, and business analysis process, led by 400+ top-tier late-stage venture capital investors, making this achievement a true testament to our mission: accelerating the future of personalized drug discovery and development through breakthrough AI technology.

This year’s Founders Games, recognized as the world’s premier global scaleup innovation competition, attracted over 4,800 leading scale ups from 150 countries, bringing together global thought leaders, major financial allocators, and industry pioneers.

It kicked off with an exclusive Davos-style breakfast featuring Binance CEO Richard Teng, Khosla Ventures’ Rajesh Swaminathan, Andrew Ng (Coursera and AI Fund), and Mercer’s Exec. Director Rich Nuzum, CFA, among other inspiring leaders.

We are deeply grateful to Webit Investment Network, Lumia, Binance, and all the partners who made this incredible journey possible. A special thanks to the esteemed Grand Finale Super Jury: Rich Nuzum, CFA, CEO and CIO of Mercer, Rajesh Swaminathan, partner at Khosla Ventures, Dr. Plamen Russev, Webit Investment Network, Hania Othman, director at The HBAR Foundation, Pawel Konzal, executive at Chevron Technology Venture, and many other distinguished leaders, for recognizing iLoF’s innovation and global impact.

A huge congratulations to our fellow winners and finalists, whose transformative solutions are reshaping industries around the world: Expedock (Philippines), QuSecure (USA), SOLAR MATERIALS (Germany), Vispek (China), Wareclouds (Chile), QuoLab Tech (USA), and NeoDocs (YC S21) (India) — was an honor to stand alongside such visionary companies

As we celebrate this incredible milestone, we remain committed to pushing the boundaries of digital health innovation and building a smarter, healthier, and more sustainable future.

The right algorithm can change lives, and yours could redefine healthcare! Ready to build the future with us? 🚀At iLoF, ...
13/02/2025

The right algorithm can change lives, and yours could redefine healthcare! Ready to build the future with us? 🚀

At iLoF, we’re on a mission to revolutionize personalized medicine, and we’re looking for a Senior Research Data Scientist to join our team! You’ll work with unique biomedical datasets, develop advanced machine learning models, and help shape the future of precision medicine.

We offer the opportunity to be part of a deep-tech company recognized by Financial Times and CB Insights as one of the most transformative companies in the world. Join us in a dynamic, flexible, and friendly environment, where you can enjoy a stimulating atmosphere that encourages creativity and innovative thinking. Contribute to our diverse, global team of scientists, innovators, and entrepreneurs dedicated to transforming personalized medicine for millions of patients worldwide! 🎯

If you’re passionate about AI, bioinformatics, and transforming healthcare, apply now by sending us a message or clicking here: https://buff.ly/3CFcSYW

We have been featured in the first episode of Dados ao Futuro, a podcast by Público exploring how data is shaping the fu...
07/02/2025

We have been featured in the first episode of Dados ao Futuro, a podcast by Público exploring how data is shaping the future ☁️🔮

In this episode, our Co-founder and CEO, Luís Valente, discussed personalized medicine and how iLoF is using artificial intelligence to analyze clinical and molecular data. This innovation is helping predict how patients respond to diseases and treatments, paving the way for more effective and tailored healthcare solutions.

🔗 Listen to the episode here: https://buff.ly/4gu8utt

Or read the full article here: https://buff.ly/4gyKwx4

A huge thank you to Público for the opportunity to share our vision and mission for the future of healthcare.

We are proud to share our latest high-impact publication on ACS Nano, a   journal in Nanocience and Nanotechnology, on o...
31/01/2025

We are proud to share our latest high-impact publication on ACS Nano, a journal in Nanocience and Nanotechnology, on our path to revolutionise personalised drug development!

Nanocarriers (NCs) hold incredible promise for targeted drug delivery, offering precise targeting and controlled release to enhance drug efficacy while reducing toxicity. But their clinical potential is held back by challenges in characterizing these complex systems.
In this publication, we introduce an innovative, cost-effective, AI-powered methodology to tackle these challenges. 🧬

This advancement represents a major leap toward bringing nanocarrier-based therapeutics to the clinic, paving the way for safer, more effective treatments. 🚀

📖 Learn more about this work here: https://buff.ly/3Cv5A9X

We are thrilled to announce a new milestone on our international expansion, having tagged alongside DayOne Health to exp...
09/01/2025

We are thrilled to announce a new milestone on our international expansion, having tagged alongside DayOne Health to expand our footprint in Basel, Switzerland! 🇨🇭🧀

Over the past few months, we’ve been immersed in the innovation ecosystem of Basel, a global hub for pharma health and technology. The support from DayOne, along with insights from leading pharmas such as Novartis, has been invaluable in helping us refine our solutions and accelerate key partnerships with pharmaceutical companies.

Our ground presence in Switzerland has been a catalyst for growth, and with DayOne’s continued support, we are confident that we will accelerate even further in driving innovation in the healthcare sector.

A big thank you to Cécile Tardy, Frank Desiere, and Ursula Costa for their incredible support.
An extra special thanks to Alan Mancoo for representing us so well

Address

Oxford

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+351220426664

Alerts

Be the first to know and let us send you an email when ILoF - Personalized Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ILoF - Personalized Medicine:

Share